Immatics (IMTX) Change in Account Payables (2020 - 2025)
Immatics' (IMTX) quarterly Change in Account Payables came in at $21.9 million in Q4 2025, down 0.86% year-on-year from $22.1 million in Q4 2024, and down 16.78% quarter-over-quarter from $26.3 million in Q3 2025.
Immatics (IMTX) Change in Account Payables (2020 - 2025) Analysis & Trends
Immatics has disclosed Change in Account Payables across 6 years of filings, most recently posting $21.9 million for Q4 2025.
- Change in Account Payables for Q4 2025 came in at $21.9 million, down 0.86% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.9 million (down 0.86% YoY), and the FY2025 annual result was $21.3 million, down 3.78% from the prior year.
- Change in Account Payables came in at $21.9 million for Q4 2025 at Immatics, down from $26.3 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $36.8 million in Q1 2022 to a low of -$20.1 million in Q4 2021.
- The 5-year median for Change in Account Payables is $21.4 million (2025), against an average of $15.4 million.
- Across the five-year window, Change in Account Payables plunged 82.9% in 2021 and surged 559.27% in 2022, its largest moves.
- Immatics' Change in Account Payables stood at -$20.1 million in 2021, then soared by 166.34% to $13.3 million in 2022, then surged by 103.6% to $27.1 million in 2023, then dropped by 18.46% to $22.1 million in 2024, then slipped by 0.86% to $21.9 million in 2025.
- The last three Change in Account Payables figures came in at $21.9 million (Q4 2025), $26.3 million (Q3 2025), and $21.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 21.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.92 Mn |
| Dec 31, 2025 | 21.92 Mn |
| Sep 30, 2025 | 26.34 Mn |
| Sep 30, 2025 | 26.34 Mn |
| Jun 30, 2025 | 21.17 Mn |
| Jun 30, 2025 | 21.17 Mn |
| Mar 31, 2025 | 19.35 Mn |
| Mar 31, 2025 | 19.35 Mn |
| Dec 31, 2024 | 22.11 Mn |
| Dec 31, 2024 | 22.11 Mn |
| Sep 30, 2024 | 24.27 Mn |
| Sep 30, 2024 | 24.27 Mn |
| Jun 30, 2024 | 20.24 Mn |
| Jun 30, 2024 | 20.24 Mn |
| Mar 31, 2024 | 22.31 Mn |
| Mar 31, 2024 | 22.31 Mn |
| Dec 31, 2023 | 27.12 Mn |
| Dec 31, 2023 | 27.12 Mn |
| Sep 30, 2023 | 21.59 Mn |
| Sep 30, 2023 | 21.59 Mn |